Tag Archives: CTBI

Top Medical Stocks To Buy For 2019

Shutterstock

One of my friends asked me this question the other day. Here’s what she said:

Nancy, I am in sales, so keeping up my appearance is important to career success. Since I turned 50, I’ve started seeing an esthetician and am getting botox injections for deep wrinkles and specialized skin care procedures. My skin looks fantastic. People tell me I look 10 years younger.  

Since these are medical procedures, can I use my HSA to pay for them?

The short answer is no. Health Savings Accounts have some pretty amazing tax benefits, so the I.R.S. has strict guidelines about HSA funds being used for “medically necessary,” rather than cosmetic, procedures.

Top Medical Stocks To Buy For 2019: McKesson Corporation(MCK)

Advisors’ Opinion:

  • [By Logan Wallace]

    Manning & Napier Group LLC cut its stake in shares of McKesson (NYSE:MCK) by 83.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,165 shares of the company’s stock after selling 16,539 shares during the period. Manning & Napier Group LLC’s holdings in McKesson were worth $445,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Motley Fool Transcribing]

    McKesson (NYSE:MCK) Q3 2019 Earnings Conference CallJan. 31, 2019 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    BB&T Securities LLC grew its position in McKesson Co. (NYSE:MCK) by 25.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 84,716 shares of the company’s stock after purchasing an additional 17,142 shares during the quarter. BB&T Securities LLC’s holdings in McKesson were worth $11,933,000 at the end of the most recent reporting period.

  • [By Paul Ausick]

    McKesson Corp. (NYSE: MCK) down about 7.5%, at $133.93 after posting a new 52-week low of $131.70. The 52-week high is $1768.86. McKesson’s market cap dropped by nearly $2.7 billion.

  • [By Lisa Levin]

    McKesson Corporation (NYSE: MCK) reported weaker-than-expected earnings for its fiscal fourth quarter.

    The company posted adjusted earnings of $3.49 per share on revenue of $51.63 billion. However, analysts were expecting earnings of $3.56 per share on revenue of $51.25 billion.

Top Medical Stocks To Buy For 2019: Community Trust Bancorp, Inc.(CTBI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Community Trust Bancorp (CTBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Community Trust Bancorp, Inc. (NASDAQ:CTBI) reached a new 52-week high and low on Wednesday . The stock traded as low as $52.30 and last traded at $52.10, with a volume of 1141 shares trading hands. The stock had previously closed at $52.05.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Community Trust Bancorp (CTBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Community Trust Bancorp (CTBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks To Buy For 2019: Heico Corporation(HEI)

Advisors’ Opinion:

  • [By Max Byerly]

    HEICO (NYSE: HEI) and TAT Technologies (NASDAQ:TATT) are both aerospace companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, institutional ownership and risk.

  • [By Travis Hoium]

    Heico Corp (NYSE:HEI) continued its strong earnings run this week, reporting strong top and bottom line growth in the fiscal third quarter of 2018. Acquisitions made over the past year are paying off on the top line, while cost discipline and a lower tax rate are helping drive growth on the bottom line. 

  • [By Shane Hupp]

    HEICO Corp (NYSE:HEI) – Equities researchers at Jefferies Group decreased their Q3 2018 earnings per share estimates for shares of HEICO in a report released on Wednesday, May 30th. Jefferies Group analyst S. Kahyaoglu now expects that the aerospace company will earn $0.55 per share for the quarter, down from their previous forecast of $0.56. Jefferies Group currently has a “Buy” rating and a $90.00 target price on the stock. Jefferies Group also issued estimates for HEICO’s Q4 2018 earnings at $0.60 EPS.

  • [By Garrett Baldwin]

    You see, seasonality and sector rotation are in play right now. That means Q3 is not often very kind to the bulls. That’s why you need to pay close attention to one of the most important indicators in the market right now. Chris explains what it is – and what to buy – right here.

    Three Stocks to Watch Today: TSLA, PFE, AAPL
    Tesla Inc. (Nasdaq: TSLA) will likely generate a lot of buzz on Monday. Three days ago, company CEO Elon Musk announced that Tesla would remain a publicly traded firm. The statement comes just weeks after Musk tweeted that he had secured investment to take the company private at $420 per share. That tweet spurred an investigation by the U.S. Securities and Exchange Commission and a lawsuit by short sellers of Tesla stock. TSLA shares were off 3% this morning. All eyes today are on Pfizer Inc. (NYSE: PFE) stock. The drug giant is poised to release the results of its phase 3 study for its drug Tafamidis. The specialty drug targets a heart disease known as transthyretin cardiomyopathy. Apple Inc. (Nasdaq: AAPL) hit a historic milestone on Aug. 2. The tech giant’s market capitalization topped $1 trillion, making it the first firm to ever hit that value. The company continues to churn profits as more firms tap into its product pipeline. AAPL stock predictions are a dime a dozen, but the fact is that this stock remains a bargain because of its price/earnings ratio. We explain why AAPL stock is still a bargain. Look for earnings reports from HEICO Corp. (NYSE: HEI) and American Wordmark Corp. (Nasdaq: AMWD).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    SpartanNash Company (NASDAQ: SPTN) is projected to post quarterly earnings at $0.53 per share on revenue of $2.38 billion.
    HP Inc. (NYSE: HPQ) is expected to post quarterly earnings at $0.48 per share on revenue of $13.57 billion.
    salesforce.com, inc. (NYSE: CRM) is projected to post quarterly earnings at $0.47 per share on revenue of $2.94 billion.
    HEICO Corporation (NYSE: HEI) is estimated to post quarterly earnings at $0.53 per share on revenue of $424.96 million.
    Safe Bulkers, Inc. (NYSE: SB) is expected to post quarterly earnings at $0.02 per share on revenue of $41.10 million

Top Medical Stocks To Buy For 2019: Bed Bath & Beyond Inc.(BBBY)

Advisors’ Opinion:

  • [By Leo Sun]

    That’s what happened to its lower-end rival Bed Bath & Beyond (NASDAQ:BBBY), which posted negative comps growth over the past five quarters. Here’s what comps growth has looked like for Williams-Sonoma’s four core brands over the past year.

  • [By Chris Lange]

    Bed Bath & Beyond Inc.’s (NASDAQ: BBBY) fiscal fourth-quarter report is scheduled for Wednesday. The consensus estimates are $1.40 in earnings per share (EPS) on $3.69 billion in revenue. The shares closed at $21.00 on Friday. The consensus price target is $22.65, and the 52-week trading range is $19.07 to $40.76.

  • [By Demitrios Kalogeropoulos]

    Shares of specialty retailer Bed Bath & Beyond (NASDAQ:BBBY) trounced the market last month by gaining 33% versus an 8% spike in the S&P 500, according to data provided by S&P Global Market Intelligence.

  • [By Garrett Baldwin]

    The secret to becoming a millionaire, of course, is getting out in front of a major investment trend before it becomes mainstream. In 2017, it was Bitcoin and cryptocurrencies. But this year, it’s a taboo investment that is creating millionaires all across North America. Tap into the “green rush,” and prepare to become a “Marijuana millionaire.” Learn how to get started right here.

    The Top Stock Market Stories for Wednesday
    U.S. President Donald Trump is facing criticism after threatening to ramp up taxes on Harley-Davidson Inc. (NYSE: HOG). The iconic motorcycle producer said it will move parts of its production overseas in order to avoid tariffs from the European Union. Trump threatened to increase taxes on the firm. “Surprised that Harley-Davidson, of all companies, would be the first to wave the White Flag,” Trump tweeted Tuesday. “I fought hard for them and ultimately they will not pay tariffs selling into the E.U., which has hurt us badly on trade, down $151 Billion. Taxes just a Harley excuse – be patient!” Earlier this month, Microsoft Corp. (Nasdaq: MSFT) launched a $7.5 billion takeover of the web-based hosting service GitHub. The acquisition, orchestrated by Microsoft CEO Satya Nadella, brought out critics who claim that GitHub lacks any real profit potential for Microsoft stock. Here’s why those critics are wrong… and why MSFT is a buy. Facebook Inc. (Nasdaq: FB) has reversed its policy on cryptocurrency ads. The social media giant says that it will permit marketing from “pre-approved advisers.” According to TechCrunch, the company will still ban ads pushing binary options and initial coin offerings. The report goes on to explain that cryptocurrency scams cost customers more than $500 million in just January and February 2018 alone.
    Four Stocks to Watch Today: ORCL, FB, GOOGL, BA
    Oracle Corp. (NYSE: ORCL) were largely flat despite a strong earnings report after the bell yesterday. The cloud computing giant reported EPS of $0.99

Best Heal Care Stocks To Own Right Now

Thermo Fisher Scientific (NYSE:TMO) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Wednesday.

According to Zacks, “Thermo Fisher ended the first quarter on a promising note with adjusted earnings and revenues surpassing the consensus mark. We are encouraged by the company’s solid international performance on strong growth in the emerging markets of China, South Korea and India. Also, a series of product launches along with major progress in precision medicine initiatives aided Thermo Fisher’s performance. Moreover, the Patheon buyout has substantially adding an impetus to the company’s value proposition for biopharma customers. Notably, it has already started to prove accretive to Thermo Fisher’s Laboratory Products and Services segment. The company has outperformed its industry in the past year. On the flip side, in the reported quarter, Thermo Fisher’s business segments were impacted by unfavorable business mix. Also, competitive headwinds and rising operating costs continue to pose a threat.”

Best Heal Care Stocks To Own Right Now: Canadian National Railway Company(CNI)

Advisors’ Opinion:

  • [By Eric Volkman]

    The problem is that owning and maintaining rail assets is ferociously expensive, and transporting humans isn’t as lucrative as hauling cargo. The major and successful publicly traded rail companies — Canadian National Railway (NYSE:CNI) and CSX (NASDAQ:CSX), to name two — all concentrate on moving stuff rather than people.

  • [By Neha Chamaria]

    Canadian National Railway (NYSE:CNI) is facing a unique problem: too much demand that it can’t seem to handle. Severe capacity shortages and delay in deliveries last quarter proved costly for the railroad, as evidenced by its just released first-quarter earnings report.

  • [By Shane Hupp]

    Shares of Canadian National Railway (NYSE:CNI) (TSE:CNR) have been assigned a consensus recommendation of “Buy” from the twenty-two ratings firms that are currently covering the firm, Marketbeat.com reports. Eleven research analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $91.71.

Best Heal Care Stocks To Own Right Now: Churchill Downs, Incorporated(CHDN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    BNP Paribas Arbitrage SA decreased its position in shares of Churchill Downs, Inc. (NASDAQ:CHDN) by 64.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,334 shares of the company’s stock after selling 2,396 shares during the period. BNP Paribas Arbitrage SA’s holdings in Churchill Downs were worth $396,000 at the end of the most recent reporting period.

  • [By ]

    More than 157,000 people attended the 2018 Kentucky Derby at Churchill Downs (Nasdaq: CHDN) to watch Triple Crown winner Justify. The iconic 143-year-old facility generates $900 million in annual revenue, with gamblers placing $11 billion in horse wagers industrywide each year — not counting what they spend away from the pari-mutuel betting windows.

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
    Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
    MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
    Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
    Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
    Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
    BioTelemetry,

Best Heal Care Stocks To Own Right Now: Community Trust Bancorp, Inc.(CTBI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Community Trust Bancorp (CTBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Community Trust Bancorp, Inc. (NASDAQ:CTBI) reached a new 52-week high and low on Wednesday . The stock traded as low as $52.30 and last traded at $52.10, with a volume of 1141 shares trading hands. The stock had previously closed at $52.05.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Community Trust Bancorp (CTBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Heal Care Stocks To Own Right Now: BioLineRx Ltd.(BLRX)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Advance Auto Parts, Inc. (NYSE: AAP) is projected to report quarterly earnings at $1.97 per share on revenue of $2.91 billion.
    Kohl's Corporation (NYSE: KSS) is expected to report quarterly earnings at $0.5 per share on revenue of $3.95 billion.
    The TJX Companies, Inc. (NYSE: TJX) is projected to report quarterly earnings at $1.02 per share on revenue of $8.47 billion.
    AutoZone, Inc. (NYSE: AZO) is estimated to report quarterly earnings at $13.01 per share on revenue of $2.72 billion.
    Dycom Industries, Inc. (NYSE: DY) is projected to report quarterly earnings at $0.7 per share on revenue of $734.86 million.
    Eaton Vance Corp. (NYSE: EV) is estimated to report quarterly earnings at $0.79 per share on revenue of $425.42 million.
    Photronics, Inc. (NASDAQ: PLAB) is expected to report quarterly earnings at $0.07 per share on revenue of $124.17 million.
    Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) is estimated to report quarterly earnings at $1.93 per share on revenue of $715.15 million.
    Radcom Ltd. (NASDAQ: RDCM) is expected to post quarterly earnings at $1.96 per share on revenue of $718.59 million.
    Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) is projected to report quarterly earnings at $0.04 per share on revenue of $718.96 million.
    CYREN Ltd. (NASDAQ: CYRN) is estimated to report quarterly loss at $0.08 per share on revenue of $7.72 million.
    Ferroglobe PLC (NYSE: GSM) is projected to report quarterly earnings at $0.16 per share on revenue of $559.15 million.
    Dr. Reddy's Laboratories Limited (NYSE: RDY) is estimated to report earnings for its fourth quarter.
    BioLineRx Ltd. (NASDAQ: BLRX) is expected to report quarterly loss at $0.07 per share.
    Toll Brothers, Inc. (NYSE: TOL) is estimated to post quarterly earnings at $0.76 per share on revenue of $1.58 billion.

     

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on BIOLINERX Ltd/S (BLRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning News Team]

    BioLine Rx Ltd. (Nasdaq: BLRX) has the cheapest share price of the three stocks on this list.

    Currently trading at $1.16 per share, this Israel-based company focuses on developing therapeutics for a range of medical needs, including serious cardiac issues, liver fibrosis, pain management, cancer, and inflammatory bowel disease.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on BIOLINERX Ltd/S (BLRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st
  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares climbed 31.68 percent to close at $7.19 on Wednesday. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares gained 24.15 percent to close at $3.29. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    21Vianet Group, Inc. (NASDAQ: VNET) shares surged 24 percent to close at $6.82.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 20.25 percent to close at $4.87.
    HUYA Inc. (NYSE: HUYA) shares surged 18.42 percent to close at $22.50
    Abaxis, Inc. (NASDAQ: ABAX) rose 16.15 percent to close at $83.34. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Pain Therapeutics, Inc. (NASDAQ: PTIE) shares jumped 16.07 percent to close at $10.62.
    Bilibili Inc. (NASDAQ: BILI) rose 16.04 percent to close at $14.11.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) gained 14.88 percent to close at $6.33.
    Phoenix New Media Limited (NYSE: FENG) rose 13.96 percent to close at $5.55.
    Daqo New Energy Corp. (NYSE: DQ) jumped 13.88 percent to close at $67.27 on Wednesday.
    Sea Limited (NYSE: SE) jumped 12.59 percent to close at $11.98 after reporting Q1 results.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 12.01 percent to close at $5.13.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) gained 11.93 percent to close at $3.19.
    Boot Barn Holdings, Inc. (NYSE: BOOT) climbed 11.66 percent to close at $24.52 on Wednesday after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Macy's, Inc. (NYSE: M) rose 10.83 percent to close at $33.17 after the company reported stronger-than-expected results for its first quarter and lifted guidance.
    ChemoCentryx, Inc. (NASDAQ: CCXI) gained 9.36 percent to close at $12.50. Canaccord Genuity initiated coverage on ChemoCentryx with a Buy rating.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX)

Best Heal Care Stocks To Own Right Now: B Communications Ltd.(BCOM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Monday afternoon, the telecommunication services shares climbed 0.69 percent. Meanwhile, top gainers in the sector included B Communications Ltd (NASDAQ: BCOM), up 5 percent, and China Unicom (Hong Kong) Limited (NYSE: CHU), up 3 percent.

Best Heal Care Stocks To Own Right Now: bluebird bio, Inc.(BLUE)

Advisors’ Opinion:

  • [By Brian Orelli]

    Sangamo Therapeutics (NASDAQ:SGMO) closed down 10.5% while bluebird bio (NASDAQ:BLUE) slipped 4.8% after competitor Global Blood Therapeutics (NASDAQ:GBT) reported positive data for its sickle cell disease drug, voxelotor.

  • [By Cory Renauer]

    Experimental treatments that use the body’s own immune system to fight cancer are nothing short of amazing. At the year’s biggest scientific conference for cancer drug developers, bluebird bio (NASDAQ:BLUE) showed us that its candidate can prolong the lives of people who had exhausted all available options.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on bluebird bio (BLUE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Rafi Farber]

    Here’s some perspective. Within the past decade, University of Pennsylvania has allied with Novartis A.G. (NYSE: NVS), Baylor College of Medicine with Bluebird Bio Inc. (NASDAQ: BLUE) and Celgene Corp. (NASDAQ: CELG), Memorial Sloan Kettering Cancer Center and the Fred Hutchinson Cancer Research Center with Juno Therapeutics Inc. (NASDAQ: JUNO) (which Celgene just got clearance to acquire), and the National Cancer Institute with Kite Pharma, which was acquired last year by Gilead Sciences Inc. (NASDAQ: GILD).

  • [By Ethan Ryder]

    Blue Protocol (CURRENCY:BLUE) traded 5.2% lower against the US dollar during the one day period ending at 18:00 PM ET on June 27th. In the last seven days, Blue Protocol has traded down 29.4% against the US dollar. Blue Protocol has a total market capitalization of $3.16 million and approximately $3,034.00 worth of Blue Protocol was traded on exchanges in the last 24 hours. One Blue Protocol token can currently be bought for approximately $0.0862 or 0.00001406 BTC on exchanges including IDEX, YoBit, CoinExchange and EtherDelta (ForkDelta).

Top Gold Stocks For 2019

Gold futures saw muted trade early Wednesday, trading near its six-month closing low as the U.S. dollars strength weighed on the precious metal.

August gold
GCQ8, -0.04%
was little changed, up 10 cents, or less than 0.1%, at $1,260 an ounce after etching out its lowest finish since Dec. 15, according to FactSet data. The dollar-pegged commodity has been on a persistent downtrend lately, with bullion down 0.8% so far this week and on pace for a monthly decline of 3.4%.

Top Gold Stocks For 2019: Community Trust Bancorp, Inc.(CTBI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Community Trust Bancorp (CTBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Community Trust Bancorp, Inc. (NASDAQ:CTBI) reached a new 52-week high and low on Wednesday . The stock traded as low as $52.30 and last traded at $52.10, with a volume of 1141 shares trading hands. The stock had previously closed at $52.05.

Top Gold Stocks For 2019: RBC Bearings Incorporated(ROLL)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    RBC Bearings (NASDAQ:ROLL) Q4 2018 Earnings Conference CallMay. 30, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Dan Caplinger]

    You don’t have to make entire aircraft in order to benefit from the huge gains in demand in the aerospace industry. Even though plane makers tend to get a lot more attention, the parts and components that go into them play a key role, and RBC Bearings’ (NASDAQ:ROLL) precision components and bearings are essential for its aerospace, defense, and industrial customers to reach their own production and sales goals. Now that it’s getting more demand across its customer spectrum than it did in past years, RBC is optimistic that things will improve from here.

  • [By Shane Hupp]

    Shares of RBC Bearings Incorporated (NASDAQ:ROLL) have earned an average rating of “Buy” from the six brokerages that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $140.67.

Top Gold Stocks For 2019: Citigroup Inc.(BLW)

Advisors’ Opinion:

  • [By Stephan Byrd]

    First Foundation Advisors reduced its position in shares of Blackrock Limited Duration (NYSE:BLW) by 8.4% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 322,389 shares of the investment management company’s stock after selling 29,591 shares during the period. First Foundation Advisors owned approximately 0.87% of Blackrock Limited Duration worth $4,862,000 as of its most recent SEC filing.

Top Gold Stocks For 2019: Amgen Inc.(AMGN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Intact Investment Management Inc. grew its holdings in Amgen (NASDAQ:AMGN) by 2,737.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 45,400 shares of the medical research company’s stock after purchasing an additional 43,800 shares during the period. Intact Investment Management Inc.’s holdings in Amgen were worth $7,739,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By ]

    Amgen (NASDAQ: AMGN) for example, announced FDA approval of its heart-attack prevention therapy on Dec 1. Immediately after, the stock popped 15% in less than two months, moving from $177.20 to $199.

  • [By Chris Lange]

    Amgen Inc. (NASDAQ: AMGN) saw its short interest fall to 9.79 million shares from the previous level of 10.46 million. Shares were last seen at $170.00, in a 52-week trading range of $152.16 to $201.23.

  • [By Max Byerly]

    Amgen (NASDAQ: AMGN) and aTyr Pharma (NASDAQ:LIFE) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, analyst recommendations and institutional ownership.

  • [By ]

    This week we get our first look at quarterly numbers from major drug and biotech giants such as AbbVie (ABBV)  , Amgen (AMGN)  , Biogen (BIIB) , Biomarin Pharmaceuticals (BMRN)  and Action Alerts PLUS holding Eli Lilly (LLY) , which all provide the market a glimpse of how the first quarter was for the industry over the next few days,” according to Real Money Pro columnist Bret Jensen.

Top Gold Stocks For 2019: CAE Inc(CAE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on CAE (CAE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Arotech (NASDAQ: ARTX) and CAE (NYSE:CAE) are both aerospace companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings and risk.

  • [By Shane Hupp]

    CAE (TSE:CAE) (NYSE:CAE) had its target price upped by investment analysts at CIBC from C$24.00 to C$27.00 in a note issued to investors on Monday. CIBC’s price objective points to a potential upside of 1.12% from the company’s current price.

Top Gold Stocks For 2019: Reading International Inc(RDI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Reading International, Inc. Class A (RDI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Reading International (RDI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com